94 related articles for article (PubMed ID: 31563162)
1. Clinical relevance of semaphorin-3F in patients with prostate cancer.
Wu G
Clin Invest Med; 2019 Sep; 42(3):E64-E69. PubMed ID: 31563162
[TBL] [Abstract][Full Text] [Related]
2. The relationship between homeobox B7 expression and the clinical characteristics of patient with prostate cancer.
Song Z; Liao Z; Cui Y; Yang C
J Cell Biochem; 2019 Apr; 120(4):6395-6401. PubMed ID: 30317675
[TBL] [Abstract][Full Text] [Related]
3. SSeCKS/AKAP12 induces repulsion between human prostate cancer and microvessel endothelial cells through the activation of Semaphorin 3F.
Xie W; Su W; Zhang L; Shang Q; Su B
Biochem Biophys Res Commun; 2017 Sep; 490(4):1394-1398. PubMed ID: 28698137
[TBL] [Abstract][Full Text] [Related]
4. Possible role of semaphorin 3F, a candidate tumor suppressor gene at 3p21.3, in p53-regulated tumor angiogenesis suppression.
Futamura M; Kamino H; Miyamoto Y; Kitamura N; Nakamura Y; Ohnishi S; Masuda Y; Arakawa H
Cancer Res; 2007 Feb; 67(4):1451-60. PubMed ID: 17308083
[TBL] [Abstract][Full Text] [Related]
5. Expression patterns of candidate susceptibility genes HNF1β and CtBP2 in prostate cancer: association with tumor progression.
Debiais-Delpech C; Godet J; Pedretti N; Bernard FX; Irani J; Cathelineau X; Cussenot O; Fromont G
Urol Oncol; 2014 May; 32(4):426-32. PubMed ID: 24332637
[TBL] [Abstract][Full Text] [Related]
6. Semaphorin-3F suppresses the stemness of colorectal cancer cells by inactivating Rac1.
Rao J; Zhou ZH; Yang J; Shi Y; Xu SL; Wang B; Ping YF; Chen L; Cui YH; Zhang X; Wu F; Bian XW
Cancer Lett; 2015 Mar; 358(1):76-84. PubMed ID: 25529012
[TBL] [Abstract][Full Text] [Related]
7. Semaphorin-3F functions as a tumor suppressor in colorectal cancer due to regulation by DNA methylation.
Gao X; Tang C; Shi W; Feng S; Qin W; Jiang T; Sun Y
Int J Clin Exp Pathol; 2015; 8(10):12766-74. PubMed ID: 26722466
[TBL] [Abstract][Full Text] [Related]
8. Id2 promotes tumor cell migration and invasion through transcriptional repression of semaphorin 3F.
Coma S; Amin DN; Shimizu A; Lasorella A; Iavarone A; Klagsbrun M
Cancer Res; 2010 May; 70(9):3823-32. PubMed ID: 20388805
[TBL] [Abstract][Full Text] [Related]
9. High expression of ASPM correlates with tumor progression and predicts poor outcome in patients with prostate cancer.
Xie JJ; Zhuo YJ; Zheng Y; Mo RJ; Liu ZZ; Li BW; Cai ZD; Zhu XJ; Liang YX; He HC; Zhong WD
Int Urol Nephrol; 2017 May; 49(5):817-823. PubMed ID: 28213802
[TBL] [Abstract][Full Text] [Related]
10. SEMA3F Promotes Liver Hepatocellular Carcinoma Metastasis by Activating Focal Adhesion Pathway.
Ye K; Ouyang X; Wang Z; Yao L; Zhang G
DNA Cell Biol; 2020 Mar; 39(3):474-483. PubMed ID: 31968181
[TBL] [Abstract][Full Text] [Related]
11. GPM6B Inhibit PCa Proliferation by Blocking Prostate Cancer Cell Serotonin Absorptive Capacity.
He S; Huang Z; Li X; Ding Y; Sheng H; Liu B; Jia Z
Dis Markers; 2020; 2020():8810756. PubMed ID: 33294057
[TBL] [Abstract][Full Text] [Related]
12. Progesterone and 1,25-dihydroxyvitamin D₃ inhibit endometrial cancer cell growth by upregulating semaphorin 3B and semaphorin 3F.
Nguyen H; Ivanova VS; Kavandi L; Rodriguez GC; Maxwell GL; Syed V
Mol Cancer Res; 2011 Nov; 9(11):1479-92. PubMed ID: 21933904
[TBL] [Abstract][Full Text] [Related]
13. Dysregulation of the annexin family protein family is associated with prostate cancer progression.
Xin W; Rhodes DR; Ingold C; Chinnaiyan AM; Rubin MA
Am J Pathol; 2003 Jan; 162(1):255-61. PubMed ID: 12507908
[TBL] [Abstract][Full Text] [Related]
14. The search for secreted proteins in prostate cancer by the Escherichia coli ampicillin secretion trap: expression of NBL1 is highly restricted to the prostate and is related to cancer progression.
Hayashi T; Sentani K; Oue N; Ohara S; Teishima J; Anami K; Sakamoto N; Matsubara A; Yasui W
Pathobiology; 2013; 80(2):60-9. PubMed ID: 22948749
[TBL] [Abstract][Full Text] [Related]
15. SEMA3F prevents metastasis of colorectal cancer by PI3K-AKT-dependent down-regulation of the ASCL2-CXCR4 axis.
Zhou ZH; Rao J; Yang J; Wu F; Tan J; Xu SL; Ding Y; Zhan N; Hu XG; Cui YH; Zhang X; Dong W; Liu XD; Bian XW
J Pathol; 2015 Aug; 236(4):467-78. PubMed ID: 25866254
[TBL] [Abstract][Full Text] [Related]
16. [Effect of downregulation of prostate cancer antigen-1 expression on malignant biological behavior of prostate cancer LNCaP cells].
Liu BQ; Wang YK; Wu YD; Wei JX; Li X
Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):828-32. PubMed ID: 24447480
[TBL] [Abstract][Full Text] [Related]
17. Prognostic impact of NDRG2 and NDRG3 in prostate cancer patients undergoing radical prostatectomy.
Ren GF; Tang L; Yang AQ; Jiang WW; Huang YM
Histol Histopathol; 2014 Apr; 29(4):535-42. PubMed ID: 24222185
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of protein kinase, DNA-activated, catalytic polypeptide attenuates tumor progression and is an independent prognostic predictor of survival in prostate cancer.
Zhang X; Wang Y; Ning Y
Urol Oncol; 2017 Mar; 35(3):111.e15-111.e23. PubMed ID: 27856181
[TBL] [Abstract][Full Text] [Related]
19. High expression of DDX20 enhances the proliferation and metastatic potential of prostate cancer cells through the NF-κB pathway.
Chen W; Zhou P; Li X
Int J Mol Med; 2016 Jun; 37(6):1551-7. PubMed ID: 27121695
[TBL] [Abstract][Full Text] [Related]
20. Differences in the Expression Pattern of mRNA Protein SEMA3F in Endometrial Cancer
Kieszkowski P; Dąbruś D; Grabarek BO; Boroń D
Curr Pharm Biotechnol; 2020; 21(11):1119-1128. PubMed ID: 32297576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
